Borosil Scientific confirms NIL encumbrance on promoter shares
Borosil Scientific Limited confirmed that its promoters and persons acting in concert (PAC) have not encumbered any equity shares during the financial year ended March 31, 2026. As of the same date, the number of encumbered shares stands at NIL. This declaration was submitted in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

*this image is generated using AI for illustrative purposes only.
Borosil Scientific Limited confirmed that its promoters and persons acting in concert (PAC) hold no encumbered equity shares as of March 31, 2026. The declaration, submitted by Promoter Pradeep Kumar Kheruka, states that no shares were pledged or encumbered directly or indirectly during the financial year ended March 31, 2026. This disclosure ensures shareholders that the promoter group's shareholding remains free from liabilities that could impact corporate control.
The confirmation was provided in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The regulation mandates periodic disclosures regarding the encumbrance status of shares held by promoters and PACs to maintain transparency in the capital markets.
Persons Acting in Concert
The declaration was made on behalf of the promoters and the following entities identified as persons acting in concert:
| Sr. No. | Name of Shareholders |
|---|---|
| 1 | Kiran Kheruka |
| 2 | Rekha Kheruka |
| 3 | Pradeep Kumar Kheruka |
| 4 | Shreevar Kheruka |
| 5 | Gujarat Fusion Glass LLP |
| 6 | Spartan Trade Holdings LLP |
| 7 | Borosil Holdings LLP |
| 8 | Associated Fabricators LLP |
| 9 | Sonargaon Properties LLP |
| 10 | Croton Trading Private Limited |
| 11 | Alaknanda Ruia |
The filing was addressed to the BSE Limited, the National Stock Exchange of India Ltd, and the Audit Committee of Borosil Scientific Limited on April 02, 2026.
Historical Stock Returns for BOROSCI
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.52% | +1.86% | +30.21% | +31.79% | +9.93% | -1.27% |
How might the zero-encumbrance status influence Borosil Scientific's ability to raise future capital or secure loans?
What impact will this disclosure have on institutional investor confidence and stock liquidity?
Does this signal a potential shift in the promoter group's strategy regarding mergers, acquisitions, or divestitures?


































